| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Carina Biotech: Advanced cellular immunotherapies We are an Australian biotech company researching and developing broad-spectrum chimeric antigen receptor T cell (CAR-T) technologies to treat solid cancers including pediatric and rare cancers. We are working to… 1. Expand the clinical indications for T cell therapies 2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States. |
| Category: | Health & biotech |
| URL: | http://carinabiotech.com |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2016 |
| Address: | Level 5, Catherine Helen Spence Building, UniSA City West Campus, Adelaide , South Australia 5000, AU |
| State: | South Australia |
| Overseas Operations: | No |
| Twitter: | [twitter-timeline username=”“] |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/carina-biotech/ |
| Founders: | |
| Awards won: | |
